S&P 500   3,311.34 (-0.31%)
DOW   29,057.99 (-0.44%)
QQQ   223.56 (-0.14%)
AAPL   317.56 (-0.04%)
FB   219.71 (-0.73%)
GOOGL   1,485.37 (+0.08%)
AMZN   1,879.29 (-0.43%)
CGC   24.39 (+1.12%)
NVDA   251.16 (+0.44%)
BABA   217.22 (-2.32%)
MU   59.13 (-0.07%)
GE   11.71 (+2.99%)
TSLA   563.25 (-1.11%)
AMD   51.13 (-0.58%)
T   38.59 (-1.15%)
ACB   2.04 (+0.00%)
F   9.05 (-1.31%)
NFLX   343.58 (+5.39%)
BAC   33.99 (-1.11%)
DIS   141.70 (-1.60%)
S&P 500   3,311.34 (-0.31%)
DOW   29,057.99 (-0.44%)
QQQ   223.56 (-0.14%)
AAPL   317.56 (-0.04%)
FB   219.71 (-0.73%)
GOOGL   1,485.37 (+0.08%)
AMZN   1,879.29 (-0.43%)
CGC   24.39 (+1.12%)
NVDA   251.16 (+0.44%)
BABA   217.22 (-2.32%)
MU   59.13 (-0.07%)
GE   11.71 (+2.99%)
TSLA   563.25 (-1.11%)
AMD   51.13 (-0.58%)
T   38.59 (-1.15%)
ACB   2.04 (+0.00%)
F   9.05 (-1.31%)
NFLX   343.58 (+5.39%)
BAC   33.99 (-1.11%)
DIS   141.70 (-1.60%)
S&P 500   3,311.34 (-0.31%)
DOW   29,057.99 (-0.44%)
QQQ   223.56 (-0.14%)
AAPL   317.56 (-0.04%)
FB   219.71 (-0.73%)
GOOGL   1,485.37 (+0.08%)
AMZN   1,879.29 (-0.43%)
CGC   24.39 (+1.12%)
NVDA   251.16 (+0.44%)
BABA   217.22 (-2.32%)
MU   59.13 (-0.07%)
GE   11.71 (+2.99%)
TSLA   563.25 (-1.11%)
AMD   51.13 (-0.58%)
T   38.59 (-1.15%)
ACB   2.04 (+0.00%)
F   9.05 (-1.31%)
NFLX   343.58 (+5.39%)
BAC   33.99 (-1.11%)
DIS   141.70 (-1.60%)
S&P 500   3,311.34 (-0.31%)
DOW   29,057.99 (-0.44%)
QQQ   223.56 (-0.14%)
AAPL   317.56 (-0.04%)
FB   219.71 (-0.73%)
GOOGL   1,485.37 (+0.08%)
AMZN   1,879.29 (-0.43%)
CGC   24.39 (+1.12%)
NVDA   251.16 (+0.44%)
BABA   217.22 (-2.32%)
MU   59.13 (-0.07%)
GE   11.71 (+2.99%)
TSLA   563.25 (-1.11%)
AMD   51.13 (-0.58%)
T   38.59 (-1.15%)
ACB   2.04 (+0.00%)
F   9.05 (-1.31%)
NFLX   343.58 (+5.39%)
BAC   33.99 (-1.11%)
DIS   141.70 (-1.60%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NYSE:EQR - Equity Residential Stock Price, Forecast & News

$82.69
+0.36 (+0.44 %)
(As of 01/23/2020 01:21 PM ET)
Today's Range
$82.18
Now: $82.69
$82.82
50-Day Range
$79.73
MA: $81.59
$84.55
52-Week Range
$69.61
Now: $82.69
$89.55
Volume28,440 shs
Average Volume1.16 million shs
Market Capitalization$30.71 billion
P/E Ratio38.82
Dividend Yield2.73%
Beta0.4
Equity Residential is an S&P 500 company focused on the acquisition, development and management of rental apartment properties located in urban and high-density suburban markets where today's renters want to live, work and play. Equity Residential owns or has investments in 307 properties consisting of 79,482 apartment units, primarily located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.

Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryResidential REITs
SectorFinance
CUSIP29476L10
Phone312-474-1300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.58 billion
Cash Flow$4.04 per share
Book Value$28.13 per share

Profitability

Net Income$657.53 million

Miscellaneous

Employees2,700
Market Cap$30.71 billion
Next Earnings Date1/28/2020 (Confirmed)
OptionableOptionable

Receive EQR News and Ratings via Email

Sign-up to receive the latest news and ratings for EQR and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

Equity Residential (NYSE:EQR) Frequently Asked Questions

What is Equity Residential's stock symbol?

Equity Residential trades on the New York Stock Exchange (NYSE) under the ticker symbol "EQR."

How often does Equity Residential pay dividends? What is the dividend yield for Equity Residential?

Equity Residential declared a quarterly dividend on Thursday, December 19th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.567 per share on Friday, January 10th. This represents a $2.27 annualized dividend and a dividend yield of 2.74%. The ex-dividend date of this dividend is Tuesday, December 31st. View Equity Residential's Dividend History.

How were Equity Residential's earnings last quarter?

Equity Residential (NYSE:EQR) released its earnings results on Tuesday, October, 22nd. The real estate investment trust reported $0.71 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.88 by $0.17. The real estate investment trust had revenue of $685.15 million for the quarter, compared to analysts' expectations of $679.66 million. Equity Residential had a return on equity of 7.73% and a net margin of 29.88%. The firm's quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.83 earnings per share. View Equity Residential's Earnings History.

When is Equity Residential's next earnings date?

Equity Residential is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Equity Residential.

How can I listen to Equity Residential's earnings call?

Equity Residential will be holding an earnings conference call on Tuesday, January 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for EQR?

12 equities research analysts have issued 12 month price targets for Equity Residential's shares. Their forecasts range from $71.00 to $90.00. On average, they anticipate Equity Residential's share price to reach $82.43 in the next year. This suggests that the stock has a possible downside of 0.3%. View Analyst Price Targets for Equity Residential.

What is the consensus analysts' recommendation for Equity Residential?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Equity Residential in the last year. There are currently 4 sell ratings, 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Equity Residential.

Has Equity Residential been receiving favorable news coverage?

News headlines about EQR stock have trended somewhat positive on Thursday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Equity Residential earned a news impact score of 1.8 on InfoTrie's scale. They also gave news headlines about the real estate investment trust a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Equity Residential.

Are investors shorting Equity Residential?

Equity Residential saw a drop in short interest in the month of December. As of December 31st, there was short interest totalling 3,850,000 shares, a drop of 14.8% from the December 15th total of 4,520,000 shares. Based on an average trading volume of 1,580,000 shares, the short-interest ratio is currently 2.4 days. Currently, 1.1% of the company's shares are short sold. View Equity Residential's Current Options Chain.

Who are some of Equity Residential's key competitors?

What other stocks do shareholders of Equity Residential own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Equity Residential investors own include Boeing (BA), Cisco Systems (CSCO), NVIDIA (NVDA), Simon Property Group (SPG), Visa (V), Starbucks (SBUX), Bank of America (BAC), Johnson & Johnson (JNJ), AT&T (T) and Walmart (WMT).

Who are Equity Residential's key executives?

Equity Residential's management team includes the folowing people:
  • Mr. Samuel Zell J.D., Founder & Chairman (Age 77)
  • Mr. Mark J. Parrell, Pres, CEO & Trustee (Age 52)
  • Mr. Alan W. George, Exec. VP & Chief Investment Officer (Age 61)
  • Mr. David S. Santee, Exec. VP of Property Operations (Age 60)
  • Mr. Robert A. Garechana, Exec. VP & CFO (Age 40)

Who are Equity Residential's major shareholders?

Equity Residential's stock is owned by a number of of institutional and retail investors. Top institutional investors include PGGM Investments (1.73%), Meag Munich Ergo Kapitalanlagegesellschaft MBH (0.07%), State of Alaska Department of Revenue (0.06%), Nisa Investment Advisors LLC (0.05%), Zurcher Kantonalbank Zurich Cantonalbank (0.05%) and Manning & Napier Group LLC (0.02%). Company insiders that own Equity Residential stock include Alan W George, Alexander Brackenridge, Barry Altshuler, Charles L Atwood, Christa L Sorenson, David J Neithercut, David S Santee, Gerald A Spector, Ian Kaufman, Linda Bynoe, Mark J Parrell, Mark S Shapiro, Michael L Manelis, Robert Garechana, Samuel Zell and Scott Fenster. View Institutional Ownership Trends for Equity Residential.

Which major investors are selling Equity Residential stock?

EQR stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Nisa Investment Advisors LLC, Campbell & CO Investment Adviser LLC, Pensionfund DSM Netherlands, Zurcher Kantonalbank Zurich Cantonalbank, Carroll Financial Associates Inc. and Pensionfund Sabic. Company insiders that have sold Equity Residential company stock in the last year include Alan W George, Alexander Brackenridge, Barry Altshuler, Charles L Atwood, Christa L Sorenson, David J Neithercut, Gerald A Spector, Ian Kaufman, Linda Bynoe, Mark J Parrell, Mark S Shapiro, Michael L Manelis, Robert Garechana, Samuel Zell and Scott Fenster. View Insider Buying and Selling for Equity Residential.

Which major investors are buying Equity Residential stock?

EQR stock was bought by a variety of institutional investors in the last quarter, including PGGM Investments, State of Alaska Department of Revenue, Bowling Portfolio Management LLC, Alpine Global Management LLC, Diversified Trust Co, RBA Wealth Management LLC, Winfield Associates Inc. and AE Wealth Management LLC. View Insider Buying and Selling for Equity Residential.

How do I buy shares of Equity Residential?

Shares of EQR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Equity Residential's stock price today?

One share of EQR stock can currently be purchased for approximately $82.70.

How big of a company is Equity Residential?

Equity Residential has a market capitalization of $30.71 billion and generates $2.58 billion in revenue each year. The real estate investment trust earns $657.53 million in net income (profit) each year or $3.25 on an earnings per share basis. Equity Residential employs 2,700 workers across the globe.View Additional Information About Equity Residential.

What is Equity Residential's official website?

The official website for Equity Residential is http://www.eqr.com/.

How can I contact Equity Residential?

Equity Residential's mailing address is TWO NORTH RIVERSIDE PLAZA SUITE 400, CHICAGO IL, 60606. The real estate investment trust can be reached via phone at 312-474-1300 or via email at [email protected]


MarketBeat Community Rating for Equity Residential (NYSE EQR)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  434 (Vote Outperform)
Underperform Votes:  813 (Vote Underperform)
Total Votes:  1,247
MarketBeat's community ratings are surveys of what our community members think about Equity Residential and other stocks. Vote "Outperform" if you believe EQR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EQR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel